Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder
NCT00320268 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600
Last updated 2009-03-25
Summary
This study is to evaluate that (SEROQUEL®) quetiapine sustained-release is efficacious and safe in the treatment of patients with MDD.
Conditions
Interventions
- DRUG
-
Quetiapine fumarate
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Art Lazarus, MD · AstraZeneca
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Completion
- 2007-05-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder
NCT00388973 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
NCT00733668 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia
NCT00085891 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
NCT00060489 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder
NCT00329446 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
NCT00351169 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia
NCT00090324 ·Status: COMPLETED ·Phase: PHASE3
-
Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression
NCT00083954 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
NCT00422214 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
NCT00351910 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression
NCT01256177 ·Status: COMPLETED ·Phase: PHASE3
-
Seroquel in Bipolar Depression Versus Lithium
NCT00206141 ·Status: COMPLETED ·Phase: PHASE3
-
Seroquel in Bipolar Depression Versus SSRI
NCT00119652 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 /Seroquel SR Acute Mania Monotherapy - US
NCT00422123 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Efficacy in Bipolar Depression Study
NCT00523601 ·Status: COMPLETED
-
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder
NCT00389064 ·Status: COMPLETED ·Phase: PHASE3
-
SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia
NCT00206115 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder
NCT00227305 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder
NCT00322595 ·Status: COMPLETED ·Phase: PHASE3
-
Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia
NCT00206128 ·Status: COMPLETED ·Phase: PHASE3
-
A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety
NCT00229645 ·Status: COMPLETED ·Phase: PHASE4
-
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania
NCT00090311 ·Status: COMPLETED ·Phase: PHASE3
-
Seroquel (Quetiapine Fumarate) InPractice Evaluation Programme
NCT00921362 ·Status: COMPLETED
-
Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
NCT00081380 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder
NCT00114686 ·Status: COMPLETED ·Phase: PHASE3